Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Treponema pallidum repeat K protein (TprK) is a member of the Tpr (Treponema pallidum repeat) gene family found in the bacterium *Treponema pallidum*, the causative agent of syphilis. TprK undergoes antigenic variation via non-reciprocal gene conversion, allowing *T. pallidum* to evade host immune responses. It is considered a therapeutic target due to its central role in syphilis pathogenesis, but its extreme variability poses challenges for vaccine development. Conserved domains are promising targets for future interventions.
N/A
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Treponema pallidum repeat K protein (None).